Last reviewed · How we verify
Chinese patent medicine — Competitive Intelligence Brief
phase 3
Small molecule
Live · refreshed every 30 min
Target snapshot
Chinese patent medicine (Chinese patent medicine) — Tianjin University of Traditional Chinese Medicine. A traditional Chinese patent medicine formulation that modulates multiple biological pathways to address disease through herbal and mineral constituents.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Chinese patent medicine TARGET | Chinese patent medicine | Tianjin University of Traditional Chinese Medicine | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Chinese patent medicine CI watch — RSS
- Chinese patent medicine CI watch — Atom
- Chinese patent medicine CI watch — JSON
- Chinese patent medicine alone — RSS
Cite this brief
Drug Landscape (2026). Chinese patent medicine — Competitive Intelligence Brief. https://druglandscape.com/ci/chinese-patent-medicine. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab